Psoriasis: Targets and Therapy
Volume 11, 2021 - Issue
Open access
189
Views
2
CrossRef citations to date
0
Altmetric
Original Research
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
Philip Hampton1 Department of Dermatology, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UKCorrespondence[email protected]
View further author information
, View further author information
Emma Borg2 LEO Pharma A/S, Ballerup, DenmarkView further author information
, Jes Birger Hansen2 LEO Pharma A/S, Ballerup, DenmarkView further author information
& Matthias Augustin3 Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyView further author information
Pages 123-131
|
Published online: 03 Nov 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.